{
    "clinical_study": {
        "@rank": "18168", 
        "arm_group": {
            "arm_group_label": "Cohesive Gel Breast Implant", 
            "arm_group_type": "Experimental", 
            "description": "Cohesive Silicone Gel-Filled Breast Implant"
        }, 
        "brief_summary": {
            "textblock": "The aim of this study is to evaluate the safety and efficacy of Cohesive Silicone Gel-Filled\n      Breast Implant (CoSBI) produced by HansBiomed co.,Ltd. in breast reconstruction or\n      augmentation"
        }, 
        "brief_title": "Clinical Trial to Evaluate the Safety and Efficacy of Cohesive Silicone Gel-Filled Breast Implant", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Breast Cancer", 
        "condition_browse": {
            "mesh_term": "Breast Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Over 22 years of age\n\n          -  Subjects who want breast augmentation reconstruction following breast cancer,\n             congenital or accidental unbalanced breast size\n\n          -  Negative pregnancy test in fertile women\n\n          -  Subjects who voluntarily decided the participation of the study and signed the\n             informed consent\n\n          -  Subjects who can understand and comply with the instructions and participate during\n             the entire period of the trial\n\n        Exclusion Criteria:\n\n          -  previous breast reconstruction or augmentation history\n\n          -  self -immune disease\n\n          -  uncontrolled active infectious disease\n\n          -  unable to insert beast implant due to radiotherapy\n\n          -  Patients who have recurrent breast cancer or do not treat effectively their cancer\n\n          -  Keloid\n\n          -  Abnormal blood test or ECG result for general anesthesia\n\n          -  Patients who cannot MRI scan due to having Metallic substance in the body or\n             Claustrophobia\n\n          -  Aesthetic addiction, drug abuse, alcohol abuse\n\n          -  Patients who are not eligible for this study at the medical discretion of the\n             Principal Investigator or Sub-investigator"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "22 Years"
        }, 
        "enrollment": {
            "#text": "108", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 18, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01711710", 
            "org_study_id": "06-2010-095", 
            "secondary_id": "E-1005-049-001"
        }, 
        "intervention": {
            "arm_group_label": "Cohesive Gel Breast Implant", 
            "description": "Cohesive Silicone Gel-Filled Breast Implant insert under the submuscular with axillary incision in breast augmentation mammoplasty.\nRemove tissue expander and insert Cohesive Silicone Gel-Filled Breast Implant in breast reconstruction.", 
            "intervention_name": "Cohesive Gel Breast Implant", 
            "intervention_type": "Device", 
            "other_name": "Cohesive Silicone Gel-Filled Breast Implant(CoSBI)"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Breast cancer", 
            "reconstruction", 
            "augmentation", 
            "cohesive silicone gel", 
            "breast implant", 
            "rupture", 
            "capsular contracture"
        ], 
        "lastchanged_date": "April 6, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Seongnam-si", 
                        "country": "Korea, Republic of", 
                        "state": "Gyeonggi-do", 
                        "zip": "463-707"
                    }, 
                    "name": "Seoul National University Bundang Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "zip": "135-710"
                    }, 
                    "name": "Samsung Medical Center"
                }
            }
        ], 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "1", 
        "official_title": "Clinical Trial to Evaluate the Safety and Efficacy of Cohesive Silicone Gel-Filled Breast Implant (CoSBI) in Women Aged 22 and Over With Breast Reconstruction or Augmentation Mammoplasty.", 
        "overall_official": {
            "affiliation": "Seoul National University Hospital", 
            "last_name": "Chanyeong Heo, Ph. D", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Korea: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "All the subjects have been monitored for 2 years and will be checked MRI to define rupture at 6month, 1 year and 2year after the breast implant.", 
                "measure": "a rate of rupture of  1%", 
                "safety_issue": "Yes", 
                "time_frame": "2 years"
            }, 
            {
                "description": "The Baker classification that divided into 4 stages will be used as a reference to evaluate the capsular contracture. Only stage 3 and 4 will be confirmed as capsular contracture.", 
                "measure": "a rate of capsular contracture of 5%", 
                "safety_issue": "Yes", 
                "time_frame": "2 years"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01711710"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Connective tissue disease include hair loss, erythema, photosensitivity, dry eye syndrome,myalgia,neuralgia,arthralgia, etc.", 
                "measure": "a rate of connective tissue disease", 
                "safety_issue": "Yes", 
                "time_frame": "2 years"
            }, 
            {
                "description": "Bra cup size can be determined by measuring right or left bust circumference over the nipple.\n6 inch= doubleA, 7inch=A, 8inch= B, 9inch=C, 10inch=D, 11inch=E Bust girth means bust circumference line . It can be determined by measuring  around the women's torso over the fullest part of the breasts.", 
                "measure": "Changes in bust girth and actual measured bra-cup size", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "description": "The subject questionaire including Rosenberg Self Esteem Scale,Body Esteem Scale,Survey of Functional-36 Status Survey  will be assessed at 6month, 1year and  2year after the intervention", 
                "measure": "Change in life satisfaction", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }
        ], 
        "source": "Seoul National University Hospital", 
        "sponsors": {
            "collaborator": {
                "agency": "HansBiomed Co.,Ltd.", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Seoul National University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2010", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}